← back to search

Kai Simons

University of Manitoba · CA
Area of research
Molecular Biology · Cell Biology
Research interest
Research interests include Biology, Type 2 diabetes, Diabetes mellitus, Disease, Cell biology, and Lipidome.
h-index
citations
1,854
works
8
NIH funding
primary concept
email

Recent publications

Genome-wide association analysis of plasma lipidome identifies 495 genetic associations
Nature Communications 2023cited by 264position: middledoi
Identification of biomarkers for glycaemic deterioration in type 2 diabetes
Nature Communications 2023cited by 43position: middledoi
Lipidome‐ and Genome‐Wide Study to Understand Sex Differences in Circulatory Lipids
Journal of the American Heart Association 2022cited by 68position: middledoi
Multi-omics profiling of living human pancreatic islet donors reveals heterogeneous beta cell trajectories towards type 2 diabetes
Nature Metabolism 2021cited by 157position: middledoi
Replication and cross-validation of type 2 diabetes subtypes based on clinical variables: an IMI-RHAPSODY study
Diabetologia 2021cited by 78position: middledoi
Distinct Molecular Signatures of Clinical Clusters in People With Type 2 Diabetes: An IMI-RHAPSODY Study
Diabetes 2021cited by 54position: middledoi
Modulation of Myelopoiesis Progenitors Is an Integral Component of Trained Immunity
Cell 2018cited by 1,044position: middledoi
A Lipid E-MAP Identifies Ubx2 as a Critical Regulator of Lipid Saturation and Lipid Bilayer Stress
Molecular Cell 2013cited by 146position: middledoi
Outdated Epinephrine Autoinjectors: Ejection Volume Integrity And Epinephrine Content And Dose
Journal of Allergy and Clinical Immunology 2012cited by 2position: firstdoi

Grants

No grants ingested yet.

Frequent collaborators

· 3 papers (2013–2023) · 2 papers (2022–2023)Sanni Ruotsalainen · University of Helsinki2 papers (2022–2023)Samuli Ripatti · Finnish Institute of Occupational Health2 papers (2022–2023)Matti Pirinen · Broad Institute2 papers (2022–2023)Elisabeth Widén · University of Helsinki2 papers (2022–2023)Rubina Tabassum · Georgia Institute of Technology2 papers (2022–2023)Mathias J. Gerl · University of Colorado Boulder2 papers (2022–2023)Ousama Rachid · University of Manitoba1 papers (2012–2012)Taru Tukiainen · Massachusetts Institute of Technology1 papers (2022–2022)Nevan J. Krogan · QB31 papers (2013–2013)Robert Ernst · University of Maryland, Baltimore1 papers (2013–2013)Debby Peng · QB31 papers (2013–2013) · 1 papers (2013–2013)David E. Gordon · University of California, San Francisco1 papers (2013–2013)Hannes Braberg · Rapt Therapeutics (United States)1 papers (2013–2013)Michał A. Surma · Genotype (Germany)1 papers (2013–2013)Michael Shales · Gladstone Institutes1 papers (2013–2013)Michael Wein · Florida State University1 papers (2012–2012) · 1 papers (2013–2013)